Antabuse: A Clinically Proven Deterrent for Alcohol Use Disorder
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.52 | $46.42 (0%) | 🛒 Add to cart |
| 120 | $0.48 | $61.89 $57.52 (7%) | 🛒 Add to cart |
| 180 | $0.46 | $92.83 $82.74 (11%) | 🛒 Add to cart |
| 270 | $0.44 | $139.25 $119.07 (14%) | 🛒 Add to cart |
| 360 | $0.43
Best per pill | $185.67 $154.39 (17%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.96 | $57.52 (0%) | 🛒 Add to cart |
| 90 | $0.85 | $86.28 $76.69 (11%) | 🛒 Add to cart |
| 120 | $0.79 | $115.03 $94.85 (18%) | 🛒 Add to cart |
| 180 | $0.73 | $172.55 $131.18 (24%) | 🛒 Add to cart |
| 270 | $0.69 | $258.83 $186.68 (28%) | 🛒 Add to cart |
| 360 | $0.68
Best per pill | $345.10 $244.19 (29%) | 🛒 Add to cart |
Synonyms | |||
Antabuse (disulfiram) is a cornerstone pharmaceutical intervention in the management of chronic alcohol use disorder (AUD). It functions as an aversive agent, creating a highly unpleasant physiological reaction upon alcohol consumption, thereby supporting patient motivation and commitment to abstinence. This medication is not a cure for alcoholism but is a powerful adjunct to a comprehensive treatment plan that includes counseling, psychosocial support, and behavioral therapy. Its efficacy is rooted in its unique mechanism of action, which provides a tangible physiological consequence for drinking, reinforcing the patient’s decision to remain sober.
Features
- Active Ingredient: Disulfiram.
- Mechanism of Action: Irreversible inhibition of the enzyme aldehyde dehydrogenase (ALDH).
- Standard Tablet Strengths: 250 mg and 500 mg.
- Administration: Oral tablet, taken once daily.
- Onset of Action: The disulfiram-ethanol reaction (DER) can occur within 10 minutes of alcohol ingestion and may persist for an hour or more.
- Duration of Effect: The inhibitory effect on ALDH can persist for up to 14 days after the last dose due to irreversible enzyme inhibition and the slow release of disulfiram from its deposit sites.
Benefits
- Creates a Powerful Psychological Deterrent: The certainty of a severe physical reaction provides a strong psychological barrier against impulsive alcohol consumption.
- Reinforces Commitment to Sobriety: The daily act of taking the medication serves as a consistent reminder and reinforcement of the patient’s commitment to an alcohol-free lifestyle.
- Provides a Structured Framework for Recovery: It offers a tangible tool within a broader treatment plan, helping patients navigate early recovery when cravings and relapse risk are highest.
- Empowers Patients: By providing a physiological “safety net,” it can reduce anxiety about succumbing to cravings and increase a patient’s sense of control over their condition.
- Facilitates Longer-Term Abstinence: By helping patients achieve and maintain initial abstinence, it creates the stability necessary for deeper psychosocial therapeutic work to take effect.
Common use
Antabuse is indicated as an adjunctive therapy in the management of selected patients with chronic alcohol use disorder who want to remain in a state of enforced sobriety. Its use is predicated on the patient’s full knowledge and consent regarding the consequences of alcohol ingestion while on the medication. It is most effective when used by motivated individuals within a supervised treatment program that includes medical, psychiatric, and social support. Ideal candidates are those who have undergone detoxification and have been free of alcohol for at least 12 hours prior to the first dose. It is not intended for use as a monotherapy or for patients who are unaware of its effects.
Dosage and direction
Initial dosing must be individualized and should not commence until the patient has abstained from alcohol for a minimum of 12 hours. A common initiation strategy involves a loading dose.
- Initial Dosage: 500 mg daily for one to two weeks.
- Maintenance Dosage: Typically ranges from 125 mg to 500 mg daily. The lower end of this range (125 mg to 250 mg) is often sufficient for maintenance and may reduce the risk of certain side effects like drowsiness or lethargy.
- Administration: The tablet should be taken once daily, preferably in the morning. It can be crushed and mixed with liquid if necessary.
- Duration of Therapy: The duration of treatment is indefinite and should be based on the patient’s ongoing commitment to sobriety and the clinical judgment of the prescribing physician. Therapy may continue for months or even years.
- Supervision: For maximum efficacy, administration should be supervised, especially in the initial stages. This can be done by a spouse, partner, or healthcare professional to ensure adherence.
Precautions
- Informed Consent: The patient must be fully informed, and preferably should provide written consent, acknowledging their understanding of the disulfiram-ethanol reaction and the necessity of avoiding all sources of alcohol.
- Alcohol Avoidance: Patients must be counseled to avoid all forms of alcohol, including hidden sources such as sauces, vinegars, mouthwashes, elixirs, tonics, colognes, and even topical preparations or fumes from solvents and paints.
- Hepatic Function: Baseline liver function tests (LFTs) are mandatory before initiation and should be monitored regularly (e.g., every 2-4 weeks initially, then every 3-6 months) during therapy due to the risk of hepatotoxicity.
- Neuropathy: Patients should be warned to report any symptoms of peripheral neuropathy, such as tingling or numbness in the extremities, as this may require discontinuation.
- Psychiatric Effects: In rare cases, disulfiram has been associated with psychotic episodes, confusion, and mood changes. Patients with a history of psychosis should be monitored closely.
- Pregnancy and Lactation: Antabuse is contraindicated in pregnancy. The risks of use during lactation likely outweigh the benefits.
Contraindications
- Hypersensitivity: Known hypersensitivity to disulfiram or any other component of the formulation.
- Recent Alcohol Use: Patients who have consumed alcohol in the past 12 hours.
- Severe Cardiac Disease: Including coronary artery disease and severe myocardial disease.
- Psychosis: A history of or current psychosis.
- Pregnancy.
- Concurrent use of alcohol-containing products or preparations.
- Concurrent use of certain drugs metabolized by CYP450 enzymes (see Drug Interactions).
Possible side effect
The most significant “side effect” is the intentional disulfiram-ethanol reaction (DER). Other common side effects of the drug itself include:
- Drowsiness, lethargy, and fatigue (often dose-dependent).
- Metallic or garlic-like aftertaste in the mouth.
- Skin eruptions, allergic dermatitis.
- Hepatotoxicity, ranging from transient transaminase elevations to rare instances of fulminant hepatitis and hepatic failure.
- Peripheral neuropathy and optic neuritis.
- Psychiatric effects such as confusion, memory impairment, and, rarely, psychotic episodes.
The Disulfiram-Ethanol Reaction (DER) includes: Flushing of the face, throbbing headache, respiratory difficulty, nausea, copious vomiting, sweating, thirst, chest pain, palpitations, tachycardia, hypotension, vertigo, blurred vision, and confusion. In severe cases, respiratory depression, cardiovascular collapse, arrhythmias, acute congestive heart failure, unconsciousness, convulsions, and death can occur.
Drug interaction
Antabuse inhibits several hepatic enzyme systems, leading to numerous potential interactions:
- Warfarin: Disulfiram potentiates the anticoagulant effect by inhibiting its metabolism, increasing the risk of bleeding. Prothrombin time must be monitored closely.
- Phenytoin: Disulfiram inhibits the metabolism of phenytoin, significantly increasing its serum levels and risk of toxicity (ataxia, nystagmus, lethargy).
- Benzodiazepines: Metabolism of certain benzodiazepines (e.g., chlordiazepoxide, diazepam) may be inhibited, potentiating their sedative effects.
- Tricyclic Antidepressants: Metabolism may be inhibited.
- Isoniazid: Concurrent use may increase the risk of central nervous system side effects, such as dizziness and unsteadiness.
- Theophylline: Disulfiram may decrease theophylline clearance, increasing the risk of toxicity.
- Metronidazole: Concomitant use is not recommended due to the potential for psychotic reactions.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is not remembered until the next day, the missed dose should be skipped, and the regular dosing schedule resumed. The patient should not double the dose to make up for the missed one. Consistency is key to maintaining the enzyme-blocking effect.
Overdose
Overdose can be severe, with symptoms including nausea, vomiting, neurological disturbances (including seizures), and cardiovascular collapse. There is no specific antidote for disulfiram overdose. Management is entirely supportive and symptomatic, focusing on:
- Gastric lavage if ingestion is recent.
- Supportive care for respiratory and cardiovascular systems.
- Monitoring and management of electrolyte imbalances.
- Treatment of seizures with benzodiazepines.
- In cases of severe toxicity, hemodialysis may be considered, though its efficacy is limited.
Storage
Store at controlled room temperature, 20°C to 25°C (68°F to 77°F). Keep the bottle tightly closed and out of reach of children. Protect from light and moisture. Do not use after the expiration date printed on the bottle.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned.
Reviews
- Clinical Evidence: “Disulfiram remains a valuable, evidence-based tool in the addiction specialist’s arsenal. Its efficacy is unequivocally tied to supervised administration and integration within a multimodal treatment model. The key to success is patient selection and thorough education.” – Journal of Substance Abuse Treatment
- Patient Experience (Typical): “After multiple failed attempts at sobriety, Antabuse gave me the physical barrier I needed to break the cycle. Knowing the severe consequences of a drink removed the daily negotiation with myself. It wasn’t easy, but it provided the stability I needed to engage properly with therapy.” – Anonymous patient in a structured recovery program.
- Expert Consensus: “While newer medications have emerged, disulfiram’s unique aversive mechanism offers a concrete consequence that some patients find necessary for accountability. Its use requires a strong therapeutic alliance and meticulous monitoring for adverse effects, particularly hepatotoxicity.” – American Society of Addiction Medicine (ASAM) Guidelines